Does Marissa Meyer know?
Multiple reports have said that Jacqueline Reses, the chief development officer of Yahoo, has been hired by Jack Dorsey’s Square Inc to head it s business financing division, Square Capital. Forbes said the hiring was done as Square closes in on its highly-anticipated initial public offering.
There has been much speculation on why Square decided to go public despite losing a lot of money. Business Insider quoted an expert on startup data, who posits that the mobile payment and merchant services aggregator may be having difficulty raising money in private markets, and is trying their luck with the public.
Re/code said Reses was one of Meyer’s closest advisers until recently. It has been suggested that Reses’ move to Square would be a harsh blow to Yahoo. Bloomberg said several top executives of Yahoo has since moved on to other companies following the search engine’s attempt to gain market share against Google and Facebook.


Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 



